Výsledky vyhledávání

Pharmacokinetics of peptide T in patients with Acquired Immunodeficiency Syndrome (AIDS)

Autor: P Heseltine, Michael R. Ruff, T P Bridge, H. Jaffe, Mark A. Gill, Kenneth H. Mayer, C Smith, T. Kingan, Pert Cb

Publikováno v: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 15:791-801

1. The pharmacokinetics of Dala1-peptide T-NH2 (peptide T) was determined during phase I clinical trials in patients with acquired immunodeficiency disease (AIDS) and AIDS related complex (ARC). Drug levels were determined by specific RIA, and in som

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a83ecf0b523e4fe1a1bf53c8a2dbb07
https://doi.org/10.1016/0278-5846(91)90008-o

Zobrazit plný text záznamu

Central Nervous System Effects of Human Immunodeficiency Virus Type 1

Autor: T P Bridge, L J Ingraham

Publikováno v: Annual Review of Medicine. 41:159-168

Following its early entry into the central nervous system (CNS), HIV-1 alters cerebral cell architecture and may subsequently affect higher cognitive functions, leading eventually in some patients to HIV-1 encephalopathy. The CNS may also be the targ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b13f4bf9c183b175a4f0511c8a2f5aa0
https://doi.org/10.1146/annurev.me.41.020190.001111

Zobrazit plný text záznamu

University of Southern California Repeatable Episodic Memory Test

Autor: T. P. Bridge, Elaine M. Eaton, Elizabeth S. Parker, P. N. R. Heseltine, S. C. Whipple

Publikováno v: Journal of clinical and experimental neuropsychology. 17(6)

The University of Southern California Repeatable Episodic Memory Test (USC-REMT) was developed to provide a brief assay of memory in clinical drug trials where the same subject is tested multiple times over days or weeks. Therefore, it had to be mini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4844951d2384a9e29390774044d3e1aa
https://pubmed.ncbi.nlm.nih.gov/8847398

Zobrazit plný text záznamu

Results of extended peptide T administration in AIDS and ARC patients

Autor: T P, Bridge, P N, Heseltine, E S, Parker, E M, Eaton, L J, Ingraham, M L, McGrail, F K, Goodwin

Publikováno v: Psychopharmacology bulletin. 27(3)

We report here the extended Phase I testing of d-ala-Peptide-T-amide (Peptide T) in open trial. The drug was given intravenously in doses ranging from 0.1 to 3.2 mg/kg/day to 14 acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a6fa63b50533919595db16377d98c7bb
https://pubmed.ncbi.nlm.nih.gov/1775594

Zobrazit plný text záznamu

Burned-out Schizophrenia: Evidence for Age Effects on Schizophrenic Symptomatology

Autor: H E Cannon, T P Bridge, Richard Jed Wyatt

Publikováno v: Journal of Gerontology. 33:835-839

The long-term outcome of chronic schizophrenia has classically been accepted to be pessimistic, most often leading to a terminal demented state. An examination of recent literature that has followed schizophrenic patients into the involutional years

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9907fcea52d747f79bbb85f876d70b1
https://doi.org/10.1093/geronj/33.6.835

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání